Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

The development was announced in a statement issued on Wednesday by the National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) under the Federal Ministry of Health and Social ...

While there was a slight increase in inpatient hospitalizations for the Red Deer clients after the OPS closed, the number of emergency department visits and “opioid-related EMS events” remained stable ...

The Federal Government says Nigeria has received Long-Acting Injectable Lenacapavir for HIV prevention, marking a new step in the country’s ...

The Federal Government has confirmed the arrival of the long-acting HIV prevention injection, Lenacapavir, marking a major ...

Biocon said its wholly owned subsidiary Biocon Pharma has received US FDA approval for its ANDA for Liraglutide Injection (gVictoza) 18 mg/3 mL prefilled pens used to treat Type 2 diabetes, following ...

Lilly said it notified the FDA of its findings and called for a nationwide recall of products containing both ingredients ...

As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop ...

Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 13 March 2026 ...

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation of Wegovy.

London's mayor and medical officer of health are voicing their support for bringing an inhalation centre to London, joining ...